Trial Profile
A randomized, open-label trial of ramelteon to prevent postoperative delirium in patients undergoing coronary artery bypass grafting
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Ramelteon (Primary)
- Indications Delirium
- Focus Therapeutic Use
- 16 Sep 2011 New trial record